pain drug

Showing 1 posts of 1 posts found.

shutterstock_4030507

Insys Therapeutics sees revenue from Subsys at $61-$62 million; shares plunge 21%

April 11, 2016
Business Services, Manufacturing and Production, Sales and Marketing Insys Therapeutics, Stock Price, Subsys, opioids, pain drug

Insys Therapeutics Inc (Nasdaq: INSY) stock plunged nearly 21% Monday after the company said sales for its pain drug will …

The Gateway to Local Adoption Series

Latest content